Brian Kenneth Roberts - 02 Mar 2026 Form 4 Insider Report for Rezolute, Inc. (RZLT)

Role: Chief Medical Officer
Signature: /s/ Brian Kenneth Roberts
Issuer symbol: RZLT
Transactions as of: 02 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 04 Mar 2026, 18:18:04 UTC
Previous filing: 17 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ROBERTS BRIAN KENNETH	Chief Medical Officer	C/O REZOLUTE, INC., 275 SHORELINE DRIVE, SUITE 500, REDWOOD CITY	/s/ Brian Kenneth Roberts	04 Mar 2026	0001829608

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	RZLT	Common Shares	Tax liability		-11,439	-3.7%	$2.99^*	296,913	02 Mar 2026	Direct	F1, F2
holding	RZLT	Common Shares						15,500	02 Mar 2026	Held in IRA

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F2	The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.07 inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Content

The disposition reported on this Form 4 represents shares disposed of by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of Restricted Stock Units ("RSUs"). The disposition is mandated by the Issuer's election to require the satisfaction of tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.

The sale price reported above is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.98 to $3.07 inclusive. The reporting person undertakes to provide to Rezolute, Inc., any security holder of Rezolute, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.